Polymorphisms in the gene encoding methylenetetrahydrofolate reductase (MTHFR), which can lead to hyperhomocysteinemia—a known vascular risk factor—have been associated with SVD and VaD in some populations [95]. This evidence concerns the gene MTHFR and hyperhomocysteinemia.